Committee on the Environment, Public Health and Food Safety | Marketing authorisations for medicinal products | 16 April 2021 | Draft Agenda


Your substances

None

This news contains references also to other Substances


The agenda on the Committee on the Environment, Public Health and Food Safety includes the following items:

(*) A reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices

(*)  Commission Delegated Regulation amending Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products

(*) Commission Regulation amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aclonifen, acrinathrin, Bacillus pumilus QST 2808, chlorantraniliprole, ethirimol, lufenuron, penthiopyrad, picloram and Pseudomonas sp. strain DSMZ 13134 in or on certain products

(*) Soil protection

CONTINUE READING ON www.europarl.europa.eu

                   

Related News

Loading...